ArticleAIDS and behavior2026
Pre-exposure Prophylaxis Outcomes from a Multilevel Cluster-Randomized Trial Among Adolescent Girls and Young Women in Tshwane, South Africa.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluating the effects of a multi-level intervention on young women's contraceptive use: sexual and reproductive health results of a cluster-randomised factorial-design study in Tshwane, South Africa.Sexual and reproductive health matters · 2025Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Pre-exposure prophylaxis (PrEP) effectively reduces HIV incidence among South African adolescent girls and young women (AGYW), but barriers to access and sustained use remain. We evaluated the effects of a clinic-level stigma and discrimination (S&D) training and the Young Women's Health CoOp (YWHC) intervention on oral PrEP outcomes among AGYW aged 16-24 years (N = 802) in Tshwane (Pretoria), South Africa. Using a modified 2 × 2 factorial cluster-randomized trial, 12 clinics and their catchment areas were assigned to one of four study arms based on receipt of S&D training for clinic staff and delivery of the YWHC intervention to AGYW. Outcomes included PrEP readiness (self-report), uptake (medical records), adherence, and persistence (dried blood spots), measured at baseline and 3-, 6-, and 9-month follow-up. Multilevel modeling showed that PrEP readiness scores were higher at follow-up among AGYW in the control arm than among those in intervention arms (p < 0.05). Differences in PrEP uptake were not statistically significant (p = 0.11), although they were clinically meaningful. AGYW attending clinics that received S&D training were more than twice as likely to initiate oral PrEP as participants in the control arm. AGYW who received the YWHC intervention were more likely to adhere to oral PrEP than those in the control arm (p ≤ 0.05). Participants in all intervention arms were also more likely to persist with PrEP use over time than controls (p < 0.05). These findings suggest that clinic- and individual-level interventions can optimize PrEP initiation, adherence, and persistence among AGYW.
Indexed as
Identifiers
42766200What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.